SAB Biotherapeutics (SABS) Q1 2023 Earnings

10MayExpected
May 22
Aug 22
Nov 22
Q1 2023
-0.17
-0.11
-0.04
0.02

Details

Expected EPS
-0.15
Actual EPS
-0.1563
Surprise EPS
-0.01
Surprise Percent
+4.2%

Description

SAB Biotherapeutics (SABS) has reported earnings of -0.1563 per share for Q1 2023.

0 Comments

Share your thoughts